BDX — BCAL Diagnostics Cashflow Statement
0.000.00%
Last trade - 00:00- AU$23.91m
- AU$20.39m
- AU$2.79m
- 36
- 18
- 26
- 16
Annual cashflow statement for BCAL Diagnostics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.243 | 0.283 | 0.4 | 0.295 | 1.04 |
| Change in Other Assets | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.525 | -0.662 | -1.21 | -3.22 | -6.05 |
| Capital Expenditures | -0.007 | -0.004 | -0.004 | -0.026 | -0.362 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | -4 | 4 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.007 | -0.004 | -0.004 | -4.03 | 3.64 |
| Financing Cash Flow Items | — | — | -0.208 | -0.622 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.5 | 0.805 | 4.2 | 9.41 | 0.013 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.032 | 0.14 | 2.99 | 2.16 | -2.4 |